← Leaderboards
Jeffrey Nicholas Myers
University Of Texas Md Anderson Can Ctr
$13,165,599
Attributed
$18,280,302
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$28,595,155 · 13
By mechanism
R01$10,118,959 · 3
U54$6,611,042 · 3
P50$4,962,759 · 2
U01$3,842,667 · 1
RC2$2,398,656 · 1
T32$542,114 · 1
Top collaborators
- Vlad C Sandulache9 shared
- Mitchell J. Frederick4 shared
- Olivier Lichtarge4 shared
- Andrew Sikora4 shared
- Richard A Gibbs2 shared
Most similar at University Of Texas Md Anderson Can Ctr
Same institution · by research overlap
- Konstantin V Sokolov$9,178,408
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorMalignant NeoplasmsResistanceHead And Neck CancerMolecularHead And Neck Squamous Cell CarcinomaDesignMutationGenomicsSignal TransductionResearch PersonnelReportingNeoplastic CellChemotherapyTp53 GeneCancer EtiologyCisplatinNeoplasm MetastasisBasePathway InteractionsMediatingCessation Of LifeCell LineResponse
Grant awards (59)
The Houston Center for Acquired Resistance Research (H-CARR)$1,172,214
U54 · FY2025 · CA · contact PI
Functional roles of GOF TP53 mutations in metastasis and immunosuppression of head and neck cancers$556,146
R01 · FY2025 · DE · contact PI
Administrative Core$195,370
U54 · FY2025 · CA · contact PI
The Houston Center for Acquired Resistance Research (H-CARR)$1,112,099
U54 · FY2024 · CA · contact PI
Functional roles of GOF TP53 mutations in metastasis and immunosuppression of head and neck cancers$545,024
R01 · FY2024 · DE · contact PI
Admin-Core-001$238,959
U54 · FY2024 · CA · contact PI
The Houston Center for Acquired Resistance Research (H-CARR)$238,959
U54 · FY2024 · CA · contact PI
Administrative Core$236,843
U54 · FY2024 · CA · contact PI
The Houston Center for Acquired Resistance Research (H-CARR)$1,174,728
U54 · FY2023 · CA · contact PI
Functional roles of GOF TP53 mutations in metastasis and immunosuppression of head and neck cancers$556,146
R01 · FY2023 · DE · contact PI
The Houston Center for Acquired Resistance Research (H-CARR)$254,772
U54 · FY2023 · CA · contact PI
Admin-Core-001$254,772
U54 · FY2023 · CA · contact PI
Administrative Core$249,452
U54 · FY2023 · CA · contact PI
The Houston Center for Acquired Resistance Research (H-CARR)$162,000
U54 · FY2023 · CA · contact PI
09 Head and Neck Cancer$18,707
P30 · FY2023 · CA · contact PI
The Houston Center for Acquired Resistance Research (H-CARR)$1,237,322
U54 · FY2022 · CA · contact PI
Functional roles of GOF TP53 mutations in metastasis and immunosuppression of head and neck cancers$556,148
R01 · FY2022 · DE · contact PI
Administrative Core$83,552
U54 · FY2022 · CA · contact PI
09 Head and Neck Cancer$18,707
P30 · FY2022 · CA · contact PI
09 Head and Neck Cancer$18,707
P30 · FY2021 · CA · contact PI
09 Head and Neck Cancer$18,675
P30 · FY2020 · CA · contact PI
09 Head and Neck Cancer$18,707
P30 · FY2019 · CA · contact PI
09 Head and Neck Cancer$5,455
P30 · FY2019 · CA · contact PI
Translating genomic alterations into novel therapeutic targets in head and neck cancer through computational and functional approaches$957,000
U01 · FY2018 · DE · contact PI
Predicting and overcoming chemoradioresistance in p53-mutant head and neck cancer$491,237
R01 · FY2018 · DE · contact PI
Progression and Metastasis of Oral Tongue Cancer$482,857
R01 · FY2018 · DE · contact PI
Translating genomic alterations into novel therapeutic targets in head and neck cancer through computational and functional approaches$957,000
U01 · FY2017 · DE · contact PI
Predicting and overcoming chemoradioresistance in p53-mutant head and neck cancer$491,237
R01 · FY2017 · DE · contact PI
Progression and Metastasis of Oral Tongue Cancer$482,857
R01 · FY2017 · DE · contact PI
Predicting and overcoming chemoradioresistance in p53-mutant head and neck cancer$64,192
R01 · FY2017 · DE · contact PI
Translating genomic alterations into novel therapeutic targets in head and neck cancer through computational and functional approaches$957,000
U01 · FY2016 · DE · contact PI
Predicting and overcoming chemoradioresistance in p53-mutant head and neck cancer$491,237
R01 · FY2016 · DE · contact PI
Progression and Metastasis of Oral Tongue Cancer$482,857
R01 · FY2016 · DE · contact PI
Translating genomic alterations into novel therapeutic targets in head and neck cancer through computational and functional approaches$971,667
U01 · FY2015 · DE · contact PI
Progression and Metastasis of Oral Tongue Cancer$497,857
R01 · FY2015 · DE · contact PI
Predicting and overcoming chemoradioresistance in p53-mutant head and neck cancer$491,237
R01 · FY2015 · DE · contact PI
Predicting and overcoming chemoradioresistance in p53-mutant head and neck cancer$521,237
R01 · FY2014 · DE · contact PI
Progression and Metastasis of Oral Tongue Cancer$351,377
R01 · FY2013 · DE · contact PI
M D Anderson Cancer Center Head & Neck SPORE$2,549,999
P50 · FY2012 · CA · contact PI
Progression and Metastasis of Oral Tongue Cancer$366,018
R01 · FY2012 · DE · contact PI
M D Anderson Cancer Center Head & Neck SPORE$2,412,760
P50 · FY2011 · CA · contact PI
Progression and Metastasis of Oral Tongue Cancer$358,624
R01 · FY2011 · DE · contact PI
Comprehensive Analysis of Genetic Alterations in Oral Cancer$1,218,121
RC2 · FY2010 · DE · contact PI
Progression and Metastasis of Oral Tongue Cancer$369,716
R01 · FY2010 · DE · contact PI
Training of Academic Head and Neck Surgical Oncologist$104,688
T32 · FY2010 · CA · contact PI
Comprehensive Analysis of Genetic Alterations in Oral Cancer$1,180,535
RC2 · FY2009 · DE · contact PI
Progression and Metastasis of Oral Tongue Cancer$373,450
R01 · FY2009 · DE · contact PI
Training of Academic Head and Neck Surgical Oncologist$92,487
T32 · FY2009 · CA · contact PI
Training of Academic Head and Neck Surgical Oncologist$75,192
T32 · FY2008 · CA · contact PI
The 7th International Conference on Head and Neck Cancer$20,000
R13 · FY2008 · DE · contact PI
Progression of Metastasis of Oral Tongue Cancer$306,038
R01 · FY2007 · DE · contact PI
Training of Academic Head and Neck Surgical Oncologist$45,681
T32 · FY2007 · CA · contact PI
Progression of Metastasis of Oral Tongue Cancer$315,178
R01 · FY2006 · DE · contact PI
Training of Academic Head and Neck Surgical Oncologist$127,188
T32 · FY2006 · CA · contact PI
Progression of Metastasis of Oral Tongue Cancer$322,763
R01 · FY2005 · DE
Progression of Metastasis of Oral Tongue Cancer$322,763
R01 · FY2004 · DE
TRAINING OF ACADEMIC HEAD AND NECK SURGICAL ONCOLOGIST$96,878
T32 · FY2004 · CA
Progression of Metastasis of Oral Tongue Cancer$322,763
R01 · FY2003 · DE
Targeting angiogenesis for therapy of head and neck cancer$0
P50 · FY2002 · CA